#WuhanPneumonia #Covid19 #Vaccine
Peru suspends clinical trials of Chinese COVID-19 vaccine as tester develops neurological problems
Peru has temporarily suspended clinical trials of a COVID-19 vaccine made by Chinese drug giant #Sinopharm after detecting neurological problems in one of its test volunteers.
The National Institute of Health in Lima said on Dec 11, 2020 that it had decided to interrupt the trial after a volunteer had difficulty moving their arms, according to local media.
"Several days ago we signalled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms which could correspond to a condition called Guillain-Barre syndrome," said chief researcher German Malaga in comments to the press.
Guillain-Barre syndrome is a rare and non-contagious disorder which affects the movement of the arms and legs. Peru declared a temporary health emergency in five regions in June last year following multiple cases.
In the 1970s a campaign to vaccinate Americans against a supposedly devastating strain of swine flu ground to a halt after about 450 of those vaccinated developed the syndrome, which can also cause paralysis.
Peru's clinical trials for the Sinopharm vaccine were due to conclude this week, after testing around 12,000 people.
Source: Channel News Asia #Dec12
https://www.channelnewsasia.com/news/world/peru-suspends-clinical-trials-china-sinopharm-covid-19-vaccine-13757116
#GuillainBarreSyndrome #Paralysis
Peru suspends clinical trials of Chinese COVID-19 vaccine as tester develops neurological problems
Peru has temporarily suspended clinical trials of a COVID-19 vaccine made by Chinese drug giant #Sinopharm after detecting neurological problems in one of its test volunteers.
The National Institute of Health in Lima said on Dec 11, 2020 that it had decided to interrupt the trial after a volunteer had difficulty moving their arms, according to local media.
"Several days ago we signalled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms which could correspond to a condition called Guillain-Barre syndrome," said chief researcher German Malaga in comments to the press.
Guillain-Barre syndrome is a rare and non-contagious disorder which affects the movement of the arms and legs. Peru declared a temporary health emergency in five regions in June last year following multiple cases.
In the 1970s a campaign to vaccinate Americans against a supposedly devastating strain of swine flu ground to a halt after about 450 of those vaccinated developed the syndrome, which can also cause paralysis.
Peru's clinical trials for the Sinopharm vaccine were due to conclude this week, after testing around 12,000 people.
Source: Channel News Asia #Dec12
https://www.channelnewsasia.com/news/world/peru-suspends-clinical-trials-china-sinopharm-covid-19-vaccine-13757116
#GuillainBarreSyndrome #Paralysis
CNA
Peru suspends clinical trials of Chinese COVID-19 vaccine
Peru has temporarily suspended clinical trials of a Covid vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in ...